HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Assessment of long-term efficacy and safety of metyrapone monotherapy in a patient with ACTH-independent macronodular adrenal hyperplasia.

AuthorsMasanori Yoshida, Hiroshi Umeda, Shintaro Iwama, Seiko Nakayama, Misaki Miyata, Koichiro Ogawa, Harumi Maeda, Yutaka Oiso
JournalEndocrine (Endocrine) Vol. 41 Issue 1 Pg. 160-1 (Feb 2012) ISSN: 1559-0100 [Electronic] United States
PMID22038492 (Publication Type: Case Reports, Letter)
Chemical References
  • Enzyme Inhibitors
  • Adrenocorticotropic Hormone
  • Steroid 11-beta-Hydroxylase
  • Metyrapone
Topics
  • Adrenal Glands (pathology, physiopathology)
  • Adrenocorticotropic Hormone (physiology)
  • Aged
  • Cushing Syndrome (drug therapy, physiopathology)
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors (adverse effects, therapeutic use)
  • Female
  • Humans
  • Hyperplasia
  • Metyrapone (adverse effects, therapeutic use)
  • Steroid 11-beta-Hydroxylase (antagonists & inhibitors)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: